
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights
Boaz Nachmias, Shlomzion Aumann, Arnon Haran, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1146-1158
Open Access | Times Cited: 8
Boaz Nachmias, Shlomzion Aumann, Arnon Haran, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1146-1158
Open Access | Times Cited: 8
Showing 8 citing articles:
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
Mariam Markouli, Maria Pagoni, Panagiotis Diamantopoulos
Frontiers in Oncology (2025) Vol. 14
Open Access
Mariam Markouli, Maria Pagoni, Panagiotis Diamantopoulos
Frontiers in Oncology (2025) Vol. 14
Open Access
piRNAs in leukemogenesis: Mechanisms, biomarkers, and therapeutic implications
Gaurav Gupta, Muhammad Afzal, Ahsas Goyal, et al.
Clinica Chimica Acta (2025), pp. 120220-120220
Closed Access
Gaurav Gupta, Muhammad Afzal, Ahsas Goyal, et al.
Clinica Chimica Acta (2025), pp. 120220-120220
Closed Access
Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import
Yuxin Xie, Ruiying Zhao, Yifan Zheng, et al.
Oncogene (2025)
Closed Access
Yuxin Xie, Ruiying Zhao, Yifan Zheng, et al.
Oncogene (2025)
Closed Access
Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy
James T. Hagen, McLane M. Montgomery, Raphael Taiwo Aruleba, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access
James T. Hagen, McLane M. Montgomery, Raphael Taiwo Aruleba, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access
Mitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy
James T. Hagen, McLane M. Montgomery, Raphael Taiwo Aruleba, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
James T. Hagen, McLane M. Montgomery, Raphael Taiwo Aruleba, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Overview of BH3 mimetics in ovarian cancer
Donatella Del Bufalo, Giovanna Damia
Cancer Treatment Reviews (2024) Vol. 129, pp. 102771-102771
Closed Access | Times Cited: 1
Donatella Del Bufalo, Giovanna Damia
Cancer Treatment Reviews (2024) Vol. 129, pp. 102771-102771
Closed Access | Times Cited: 1
Boanmycin induces apoptosis and overcomes venetoclax resistance in acute myeloid leukemia
Jin‐Xing Wang, Pengwei Zhang, Luo‐Wei Yuan, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 5, pp. 743-752
Closed Access | Times Cited: 1
Jin‐Xing Wang, Pengwei Zhang, Luo‐Wei Yuan, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 5, pp. 743-752
Closed Access | Times Cited: 1
Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials
Fatimah Alharbi, Eyad Almanifi, Md. Ashrafuzzaman
Medicine in Drug Discovery (2024), pp. 100199-100199
Open Access
Fatimah Alharbi, Eyad Almanifi, Md. Ashrafuzzaman
Medicine in Drug Discovery (2024), pp. 100199-100199
Open Access